CBLI

Cytocom, Inc. CBLI

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CBLI INXB SLRN MACK CATB CRGX TCRT CELU SPPI THRD
6M 0.00 % 13.94 % -27.94 % 14.39 % 0.00 % 17.63 % 9.80 % 28.21 % 31.75 % 53.71 %
YTD 0.00 % 13.94 % -31.21 % 13.79 % 0.00 % -70.30 % 36.55 % -9.09 % 167.97 % -51.27 %
1Y 252.18 % 13.94 % -42.96 % 21.55 % 0.00 % -81.53 % 30.58 % 16.96 % -10.87 % -60.15 %
3Y 56.93 % -90.67 % -87.39 % 136.64 % 0.00 % -69.24 % -98.49 % -91.45 % -75.65 % -68.35 %
5Y -2.46 % -90.67 % -87.39 % 240.34 % 0.00 % -69.24 % -99.19 % -98.06 % -95.47 % -68.35 %
10Y -90.73 % 1 486.00 % -87.39 % -74.80 % 0.00 % -69.24 % -99.85 % -97.96 % -86.62 % -68.35 %
From the beginning -97.01 % 1 486.00 % -87.39 % -68.13 % 0.00 % -69.24 % -99.89 % -97.96 % -99.25 % -68.35 %

Dividend

Merrimack Pharmaceuticals, Inc.

Spectrum Pharmaceuticals, Inc.

Third Harmonic Bio, Inc.